TELADOC HEALTH, INC. Capitalized Computer Software, Amortization
TELADOC HEALTH, INC. (TDOC) reported Capitalized Computer Software, Amortization of $38.08 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CapitalizedComputerSoftwareAmortization1 · last filed 2026-04-30
- TELADOC HEALTH, INC. capitalized computer software, amortization for the quarter ending 2026-03-31 was $38.08M, a 9.11% decline year-over-year.
- TELADOC HEALTH, INC. capitalized computer software, amortization for the quarter ending 2025-12-31 was $39.20M, a 10.16% increase year-over-year.
- TELADOC HEALTH, INC. capitalized computer software, amortization for the quarter ending 2025-09-30 was $42.23M, a 17.92% increase year-over-year.
- TELADOC HEALTH, INC. capitalized computer software, amortization for the quarter ending 2025-06-30 was $44.29M, a 43.99% increase year-over-year.
- TELADOC HEALTH, INC. capitalized computer software, amortization for fiscal 2025 was $167.62M, a 25.99% increase from fiscal 2024.
- TELADOC HEALTH, INC. capitalized computer software, amortization for fiscal 2024 was $133.04M, a 60.37% increase from fiscal 2023.
- TELADOC HEALTH, INC. capitalized computer software, amortization for fiscal 2023 was $82.96M, a 79.96% increase from fiscal 2022.
- TELADOC HEALTH, INC. capitalized computer software, amortization for fiscal 2022 was $46.10M, a 206.32% increase from fiscal 2021.
| Period end | Capitalized Computer Software, Amortization 3 month | Capitalized Computer Software, Amortization 3 month as first filed | Capitalized Computer Software, Amortization 6 month | Capitalized Computer Software, Amortization 6 month as first filed | Capitalized Computer Software, Amortization 9 month | Capitalized Computer Software, Amortization 12 month | Capitalized Computer Software, Amortization 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | $38.08M 10-Q · filed 2026-04-30 | $77.27M derived: sum of 2 quarters · filed 2026-04-30 | $119.51M derived: sum of 3 quarters · filed 2026-04-30 | $163.80M derived: sum of 4 quarters · filed 2026-04-30 | |||
| 2025-12-31 | $39.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $81.43M derived: sum of 2 quarters · filed 2026-02-26 | $125.72M derived: sum of 3 quarters · filed 2026-02-26 | $167.62M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $42.23M 10-Q · filed 2025-10-30 | $86.53M derived: sum of 2 quarters · filed 2025-10-30 | $128.42M 10-Q · filed 2025-10-30 | $164.00M derived: sum of 4 quarters · filed 2026-04-30 | |||
| 2025-06-30 | $44.29M 10-Q · filed 2025-07-30 | $86.19M 10-Q · filed 2025-07-30 | $121.77M derived: sum of 3 quarters · filed 2026-04-30 | $157.59M derived: sum of 4 quarters · filed 2026-04-30 | |||
| 2025-03-31 | $41.89M 10-Q · filed 2026-04-30 | $77.48M derived: sum of 2 quarters · filed 2026-04-30 | $113.29M derived: sum of 3 quarters · filed 2026-04-30 | $144.05M derived: sum of 4 quarters · filed 2026-04-30 | |||
| 2024-12-31 | $35.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $71.40M derived: sum of 2 quarters · filed 2026-02-26 | $102.16M derived: sum of 3 quarters · filed 2026-02-26 | $133.04M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $35.82M 10-Q · filed 2025-10-30 | $66.58M derived: sum of 2 quarters · filed 2025-10-30 | $97.45M 10-Q · filed 2025-10-30 | $121.42M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | $30.76M 10-Q · filed 2025-07-30 | $61.64M 10-Q · filed 2025-07-30 | $85.60M derived: sum of 3 quarters · filed 2026-02-26 | $108.24M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | $30.88M 10-Q · filed 2025-05-01 | $54.84M derived: sum of 2 quarters · filed 2026-02-26 | $77.48M derived: sum of 3 quarters · filed 2026-02-26 | $97.23M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | $23.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $46.61M derived: sum of 2 quarters · filed 2026-02-26 | $66.36M derived: sum of 3 quarters · filed 2026-02-26 | $82.96M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | $22.64M 10-Q · filed 2024-10-31 | $42.39M derived: sum of 2 quarters · filed 2024-10-31 | $58.99M 10-Q · filed 2024-10-31 | $81.92M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-06-30 | $19.75M 10-Q · filed 2024-08-01 | $19.70M 10-Q · filed 2023-07-28 | $36.35M 10-Q · filed 2024-08-01 | $36.30M 10-Q · filed 2023-07-28 | $59.27M derived: sum of 3 quarters · filed 2025-02-27 | $68.80M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $16.60M 10-Q · filed 2024-04-26 | $16.60M 10-Q · filed 2023-05-02 | $39.52M derived: sum of 2 quarters · filed 2025-02-27 | $49.05M derived: sum of 3 quarters · filed 2025-02-27 | $56.05M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $22.92M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $32.45M derived: sum of 2 quarters · filed 2025-02-27 | $39.45M derived: sum of 3 quarters · filed 2025-02-27 | $46.10M 10-K · filed 2025-02-27 | $46.10M 10-K · filed 2023-03-01 | ||
| 2022-09-30 | $9.52M 10-Q · filed 2023-10-27 | $16.52M derived: sum of 2 quarters · filed 2023-10-27 | $23.18M 10-Q · filed 2023-10-27 | ||||
| 2022-06-30 | $7.00M 10-Q · filed 2023-07-28 | $13.70M 10-Q · filed 2023-07-28 | |||||
| 2022-03-31 | $6.70M 10-Q · filed 2023-05-02 | ||||||
| 2021-12-31 | $15.05M 10-K · filed 2024-02-23 | $15.00M 10-K · filed 2023-03-01 | |||||
| 2020-12-31 | $7.50M 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |